TIORFANOR 175 mg, film-coated tablet 12 tablets
Active ingredients: Racecadotril
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TIORFANOR 175 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 12 comprimé(s)
- Marketing authorisation holder
- BIOPROJET PHARMA (FRANCE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jan 2009
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66873973CIP73820034CIP133400938200348Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RACÉCADOTRILcomprimé | 175 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.